Pepe, G., Capocci, L., Marracino, F., Realini, N., Lenzi, P., Martinello, K., Bovier, T. F., Bichell, T. J., Scarselli, P., Di Cicco, C., Bowman, A. B., Digilio, F. A., Fucile, S., Fornai, F., Armirotti, A., Parlato, R., Di Pardo, A., & Maglione, V. (2023). Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease. Molecular Therapy, 31(1), 282–299. https://doi.org/10.1016/j.ymthe.2022.09.004